Brief: Scienture Announces Manufacturing And Supply Chain Readiness For ArbliTM, (Losartan Potassium) Oral Suspension, 10Mg/Ml For A Target Product Launch In July 2025
22/04/2025 13:48
April 22 (Reuters) - Scienture Holdings Inc SCNX.O: SCIENTURE ANNOUNCES MANUFACTURING AND SUPPLY CHAIN READINESS FOR ARBLITM, (LOSARTAN POTASSIUM) ORAL SUSPENSION, 10MG/ML FOR A TARGET PRODUCT LAUNCH IN JULY 2025. Source text: ID:nGNX9fWcNx Further company coverage: SCNX.O ((Reuters.Briefs@thomsonreuters.com;))